A gap in Nisbett and Wilson's findings? A first-person access to our cognitive processes.

Conscious Cogn

Institut Mines-Télécom (Télécom EM), 9, rue Charles Fourier, 91011 Evry, France.

Published: June 2013

The well-known experiments of Nisbett and Wilson lead to the conclusion that we have no introspective access to our decision-making processes. Johansson et al. have recently developed an original protocol consisting in manipulating covertly the relationship between the subjects' intended choice and the outcome they were presented with: in 79.6% of cases, they do not detect the manipulation and provide an explanation of the choice they did not make, confirming the findings of Nisbett and Wilson. We have reproduced this protocol, while introducing for some choices an expert guidance to the description of this choice. The subjects who were assisted detected the manipulation in 80% of cases. Our experiment confirms Nisbett and Wilson's findings that we are usually unaware of our decision processes, but goes further by showing that we can access them through specific mental acts.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.concog.2013.02.004DOI Listing

Publication Analysis

Top Keywords

nisbett wilson's
8
nisbett wilson
8
gap nisbett
4
wilson's findings?
4
findings? first-person
4
first-person access
4
access cognitive
4
cognitive processes
4
processes well-known
4
well-known experiments
4

Similar Publications

Background: Paediatric multisystem inflammatory syndrome temporally associated with SARS-CoV-2 (PIMS-TS), also known as multisystem inflammatory syndrome in children (MIS-C) emerged in April, 2020. The paediatric comparisons within the RECOVERY trial aimed to assess the effect of intravenous immunoglobulin or corticosteroids compared with usual care on duration of hospital stay for children with PIMS-TS and to compare tocilizumab (anti-IL-6 receptor monoclonal antibody) or anakinra (anti-IL-1 receptor antagonist) with usual care for those with inflammation refractory to initial treatment.

Methods: We did this randomised, controlled, open-label, platform trial in 51 hospitals in the UK.

View Article and Find Full Text PDF

Background: Empagliflozin has been proposed as a treatment for COVID-19 on the basis of its anti-inflammatory, metabolic, and haemodynamic effects. The RECOVERY trial aimed to assess its safety and efficacy in patients admitted to hospital with COVID-19.

Methods: In the randomised, controlled, open-label RECOVERY trial, several possible treatments are compared with usual care in patients hospitalised with COVID-19.

View Article and Find Full Text PDF
Article Synopsis
  • * The FLO-ELA trial is described as a large-scale study involving over 3,100 patients aged 50 and older, comparing heart-monitoring guided fluid management to standard care.
  • * The main goal of the trial is to measure how many days patients are alive and out of the hospital within 90 days post-surgery, and it aims to provide evidence to improve clinical practices in emergency surgical settings.
View Article and Find Full Text PDF
Article Synopsis
  • A study evaluated the effects of a higher dose of corticosteroids on COVID-19 patients who needed oxygen or ventilatory support, building on previous findings that low-dose corticosteroids reduced mortality in similar patients.
  • The research was part of the RECOVERY trial, which randomly assigned patients to receive either higher dose corticosteroids or usual care with a lower dose, measuring 28-day mortality rates as the primary outcome.
  • From May 2021 to May 2022, 1,272 patients were included, with notable participation from Asia and the UK; results showed that nearly all of the patients who received usual care also received some form of low-dose corticosteroids.
View Article and Find Full Text PDF
Article Synopsis
  • Anterior cruciate ligament (ACL) ruptures can severely affect knee stability, leading researchers to compare reconstructive surgery and non-surgical rehabilitation in patients with persistent instability symptoms.
  • A randomized controlled trial involved 316 patients across 29 UK NHS orthopedic units, with participants split into surgical and rehabilitation groups, primarily assessing outcomes using the Knee Injury and Osteoarthritis Outcome Score-4 at 18 months.
  • Results showed that the surgical group had a higher average KOOS4 score (73.0) compared to the rehabilitation group (64.6), indicating that surgery may be more effective; however, many patients in the rehabilitation group later opted for surgery.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!